Results 111 to 120 of about 293,480 (309)

The Transition to Smoking Cessation: Evidence from Multiple Failure Duration Analysis [PDF]

While much is known about the impacts prices and tobacco control policies have on smoking participation and frequency of cigarette use, little is known about their impacts on smoking cessation. This paper addresses the dynamics of smoking cessation using
John A. Tauras
core  

Consumer Behavior Toward Health‐Related Mobile Applications: A Hybrid Review and Future Agenda

Journal of Consumer Behaviour, EarlyView.
ABSTRACT Mobile health (MH) has the potential to address many consumer challenges, but consumer responses to it remain varied. In this regard, the consumer's perspective on MH is becoming increasingly attractive to academia and business. This review aims to synthesize and analyze 103 studies from 2010 to 2024 using the Scientific Procedures and ...
Omer Faruk Celebi, Ebru Tumer, Nilsah Cavdar Aksoy, Alev Kocak Alan   +3 more
wiley   +1 more source

The Association of Socioeconomic and Environmental Factors with Smoking Cessation [PDF]

, 2018
Background: Smoking cessation rates have remained stagnant globally. Environment factor plays an important role in the likelihood of achieving quitting from smoking.
Atmojo, J. T. (Joko ), Murti, B. (Bhisma ), Soemanto, R. (RB )   +2 more
core  

Toward an mHealth Intervention for Smoking Cessation [PDF]

, 2013
The prevalence of tobacco dependence in the United States (US) remains alarming. Invariably, smoke-related health problems are the leading preventable causes of death in the US.
Addo, Ivor D., Ahamed, Sheikh Iqbal, Ahsan, Golam Mushih Tanimul, Burhansstipanov, Linda, Kanekar, Shalini, Krebs, Linda U., Petereit, Daniel   +6 more
core   +2 more sources

Smoking cessation and COPD [PDF]

European Respiratory Review, 2013
The mainstay in smoking cessation is counselling in combination with varenicline, nicotine replacement therapy (NRT) or bupropion SR. Varenicline and combination of two NRTs is equally effective, while varenicline alone is more effective than either NRT or bupropion SR.
openaire   +3 more sources

Cardiovascular Risk Assessment and Its Determinants Among Older Adults in India: Evidence From a Nationally Representative Survey

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Background Cardiovascular disease (CVD) is the leading cause of mortality, posing a major challenge to its rapidly aging demographic. Early identification of individuals at high risk for future cardiovascular events is paramount for implementing timely preventative strategies.
Vansh Maheshwari, Shyamashree Das, Saurav Basu   +2 more
wiley   +1 more source

Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysis

Drug and Alcohol Dependence Reports
Nicotine pouches (NP) are novel agents that deliver nicotine through buccal absorption as opposed to combustion. They are proposed as a harm reduction tool compared to smoking tobacco. However, there is limited evidence on their efficacy and safety. This
Javad Heshmati, Emma Lynn Bates, Spencer Shahen, Sarah Visintini, Evyanne Quirouette, Kerri-Anne Mullen, Hassan Mir   +6 more
doaj   +1 more source

A ‘Cut-Down-To-Stop’ intervention for smokers who find it hard to quit: a qualitative evaluation

BMC Public Health, 2019
Background English Stop Smoking Services primarily deliver behavioural interventions to support abrupt quit attempts. Recent evidence suggests an alternative approach could be offered to clients involving a more gradual reduction of cigarettes smoked ...
J. Robinson, A. McEwen, R. Heah, S. Papadakis   +3 more
doaj   +1 more source

Persistence of oxidant and protease burden in the airways after smoking cessation [PDF]

, 2009
Background:Oxidative stress is associated with the pathogenesis of cigarette smoke related lung diseases, but longitudinal effects of smoking cessation on oxidant markers in the airways are unknown.
Noora Louhelainen, Paula Rytilä, Tari Haahtela, Vuokko L Kinnula, Ratko Djukanović, KF Rabe, NS Godtfredsen, T Haahtela, V Siroux, R Chaudhuri, BW Willemse, E Gamble, VL Kinnula, P Rytilä, PT Elkington, EA Kelly, WC Parks, VL Kinnula, KK Nelson, H Ilumets, PH Quanjer, R Djukanovic, C Hadjicharalambous, R Louis, N Louhelainen, W Mazur, PD Scanlon, P Aveyard, D Gorecka, T Lancaster, G Stratelis, A Bhowmik, SR Rutgers, G Turato, C Yamamoto, U Costabel, CS Ulrik, GW Chalmers, R Chaudhuri, B Pedersen, GW Chalmers, P Montuschi, JD Morrow, LJ Janssen, LG Wood, E Baraldi, P Montuschi, P Montuschi, CT Carpenter, P Montuschi, SA Kharitonov, AD Smith, B Balint, M Corradi, SR Rutgers, W Maziak, SA Kharitonov, M Ichinose, E Sapey   +58 more
core   +2 more sources

A Survival Epidemiology Framework for Oral and Oropharyngeal Cancer

Cancer Nexus, EarlyView.
ABSTRACT Oral and oropharyngeal cancer remains a major global public health burden, but the literature addressing this disease is still organized predominantly around who develops it rather than around what determines life after diagnosis. That imbalance is consequential because diagnosis initiates a new scientific problem.
Raphael E. Cuomo
wiley   +1 more source